Literature DB >> 21190055

SOX2 gene expression in normal human thymus and thymoma.

Anca Maria Cimpean1, Svetlana Encica, Marius Raica, Domenico Ribatti.   

Abstract

The SOX gene family encodes a large group of transcription factors that are strongly involved in the normal human development and malignancies. Human tumors, like small cell lung carcinoma, meningioma, gastric, and pancreatic cancer, have been found to be immunogenic for SOX2 protein. In this study, we have investigated for the first time the expression and distribution of SOX2 immunoreactive cells in five normal human thymuses (2 fetal and 3 adult) and 10 thymomas bioptic specimens. Results demonstrated the presence of few positive cells in the fetal and postnatal normal human thymus with a specific distribution within thymus parenchyma compartments. On the contrary, in thymoma immunoreactivity to SOX2 increased parallel to pathological stage, and a peculiar distribution was observed in type B3 thymoma with a positive reaction in both tumor and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190055     DOI: 10.1007/s10238-010-0127-0

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  29 in total

Review 1.  Thymus organogenesis and molecular mechanisms of thymic epithelial cell differentiation.

Authors:  N R Manley
Journal:  Semin Immunol       Date:  2000-10       Impact factor: 11.130

Review 2.  Cellular and molecular events during early thymus development.

Authors:  Georg Holländer; Jason Gill; Saulius Zuklys; Norimasa Iwanami; Cunlan Liu; Yousuke Takahama
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 3.  Thymus organogenesis.

Authors:  Hans-Reimer Rodewald
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  p63 Is essential for the proliferative potential of stem cells in stratified epithelia.

Authors:  Makoto Senoo; Filipa Pinto; Christopher P Crum; Frank McKeon
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

5.  Expression of p63 in thymomas and normal thymus.

Authors:  Jorge Dotto; Giuseppe Pelosi; Juan Rosai
Journal:  Am J Clin Pathol       Date:  2007-03       Impact factor: 2.493

Review 6.  A roadmap for thymic epithelial cell development.

Authors:  Graham Anderson; Eric J Jenkinson; Hans-Reimer Rodewald
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

7.  Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression.

Authors:  Yasuyo Tani; Yoshimitsu Akiyama; Hiroshi Fukamachi; Kazuyoshi Yanagihara; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-28       Impact factor: 4.553

8.  SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Authors:  Rosaria Maria Rita Gangemi; Fabrizio Griffero; Daniela Marubbi; Marzia Perera; Maria Cristina Capra; Paolo Malatesta; Gian Luigi Ravetti; Gian Luigi Zona; Antonio Daga; Giorgio Corte
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

Review 9.  Histologic and molecular assessment of human thymus.

Authors:  Laura P Hale
Journal:  Ann Diagn Pathol       Date:  2004-02       Impact factor: 2.090

10.  Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

Authors:  Socorro M Rodriguez-Pinilla; David Sarrio; Gema Moreno-Bueno; Yolanda Rodriguez-Gil; Miguel A Martinez; Lucia Hernandez; David Hardisson; Jorge S Reis-Filho; Jose Palacios
Journal:  Mod Pathol       Date:  2007-03-02       Impact factor: 7.842

View more
  8 in total

1.  Single-cell chromatin profiling of the primitive gut tube reveals regulatory dynamics underlying lineage fate decisions.

Authors:  Ryan J Smith; Hongpan Zhang; Shengen Shawn Hu; Theodora Yung; Roshane Francis; Lilian Lee; Mark W Onaitis; Peter B Dirks; Chongzhi Zang; Tae-Hee Kim
Journal:  Nat Commun       Date:  2022-05-26       Impact factor: 17.694

2.  Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.

Authors:  Ki Yeon Kim; Gwanghee Lee; Minsang Yoon; Eun Hye Cho; Chan-Sik Park; Moon Gyo Kim
Journal:  Mol Cells       Date:  2015-05-27       Impact factor: 5.034

3.  The Sox2 promoter-driven CD63-GFP transgenic rat model allows tracking of neural stem cell-derived extracellular vesicles.

Authors:  Aya Yoshimura; Naoki Adachi; Hitomi Matsuno; Masaki Kawamata; Yusuke Yoshioka; Hisae Kikuchi; Haruki Odaka; Tadahiro Numakawa; Hiroshi Kunugi; Takahiro Ochiya; Yoshitaka Tamai
Journal:  Dis Model Mech       Date:  2018-01-30       Impact factor: 5.758

4.  Genetic characterization of thymoma.

Authors:  Lei Yu; Ji Ke; Xin Du; Zhen Yu; Di Gao
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

5.  The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Authors:  Paul Maddison; Maarten J Titulaer; Jan J Verschuuren; Paul Gozzard; Bethan Lang; Sarosh R Irani; Lidia Sabater; Francesc Graus; Andrea Murray; Caroline J Chapman
Journal:  J Neuroimmunol       Date:  2018-11-08       Impact factor: 3.478

6.  Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma.

Authors:  P Gelebart; S A Hegazy; P Wang; K M Bone; M Anand; D Sharon; M Hitt; J D Pearson; R J Ingham; Y Ma; R Lai
Journal:  Blood Cancer J       Date:  2012-08-10       Impact factor: 11.037

7.  SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.

Authors:  Ida V Lundberg; Anna Löfgren Burström; Sofia Edin; Vincy Eklöf; Åke Öberg; Roger Stenling; Richard Palmqvist; Maria L Wikberg
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

8.  Identification of a Transcription Factor-microRNA-Gene Coregulation Network in Meningioma through a Bioinformatic Analysis.

Authors:  Juan Wang; Yan Liang; Hui Yang; Jian-Huang Wu
Journal:  Biomed Res Int       Date:  2020-08-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.